AU2017183A - Adenocarcinoma antigenic determinates and antibodies and reagent systems - Google Patents

Adenocarcinoma antigenic determinates and antibodies and reagent systems

Info

Publication number
AU2017183A
AU2017183A AU20171/83A AU2017183A AU2017183A AU 2017183 A AU2017183 A AU 2017183A AU 20171/83 A AU20171/83 A AU 20171/83A AU 2017183 A AU2017183 A AU 2017183A AU 2017183 A AU2017183 A AU 2017183A
Authority
AU
Australia
Prior art keywords
adenocarcinoma
antibodies
reagent systems
antigenic determinates
determinates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU20171/83A
Other languages
English (en)
Inventor
Alberto Bartorelli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmitalia Carlo Erba SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmitalia Carlo Erba SRL filed Critical Farmitalia Carlo Erba SRL
Publication of AU2017183A publication Critical patent/AU2017183A/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57565Immunoassay; Biospecific binding assay; Materials therefor for cancer involving carcinoembryonic antigen [CEA]
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5753Immunoassay; Biospecific binding assay; Materials therefor for cancer of the stomach or small intestine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU20171/83A 1983-06-23 1983-10-14 Adenocarcinoma antigenic determinates and antibodies and reagent systems Abandoned AU2017183A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB838317022A GB8317022D0 (en) 1983-06-23 1983-06-23 Adenocarcinoma related new antigenic determinants
GB8317022 1983-06-23

Publications (1)

Publication Number Publication Date
AU2017183A true AU2017183A (en) 1985-01-03

Family

ID=10544654

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20171/83A Abandoned AU2017183A (en) 1983-06-23 1983-10-14 Adenocarcinoma antigenic determinates and antibodies and reagent systems

Country Status (13)

Country Link
JP (1) JPS6018765A (fr)
AU (1) AU2017183A (fr)
BE (1) BE899484A (fr)
DE (1) DE3337465A1 (fr)
DK (1) DK476083A (fr)
FI (1) FI833742L (fr)
FR (1) FR2548901A1 (fr)
GB (1) GB8317022D0 (fr)
IT (1) IT1194429B (fr)
NL (1) NL8303571A (fr)
NO (1) NO833756L (fr)
SE (1) SE8305667L (fr)
ZA (1) ZA837673B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2589630B2 (ja) * 1992-06-12 1997-03-12 ゼニヤ海洋サービス株式会社 砂防ダム用放水装置

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4086217A (en) * 1976-03-03 1978-04-25 Hoffmann-La Roche Inc. Carcinoembryonic antigens
US4145336A (en) * 1976-04-30 1979-03-20 Scripps Clinic And Research Foundation Carcinoembryonic antigen isomer
US4315851A (en) * 1978-12-29 1982-02-16 Kureha Kagaku Kogyo Kabushiki Kaisha Pharmaceutical composition having antitumor activity
US4349528A (en) * 1979-11-21 1982-09-14 The Wistar Institute Monocolonal hybridoma antibody specific for high molecular weight carcinoembryonic antigen
EP0044167A3 (fr) * 1980-07-14 1982-04-21 The Regents Of The University Of California Agent cytotoxique dirigé par un anticorps
EP0072902B1 (fr) * 1981-08-21 1985-04-24 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Procédé pour la détermination des antigènes carcinoembryonnaires (CEA) et pour la détermination appropriée de solution d'anticorps
DE3230299A1 (de) * 1982-08-14 1984-02-16 Hoechst Ag, 6230 Frankfurt Carcinoembryonales antigen, verfahren zu seiner isolierung und seine verwendung

Also Published As

Publication number Publication date
FR2548901A1 (fr) 1985-01-18
DE3337465A1 (de) 1985-01-03
ZA837673B (en) 1984-08-29
FI833742A7 (fi) 1984-12-24
IT8323351A0 (it) 1983-10-19
NO833756L (no) 1984-12-27
DK476083D0 (da) 1983-10-14
SE8305667D0 (sv) 1983-10-14
BE899484A (fr) 1984-10-22
SE8305667L (sv) 1984-12-24
GB8317022D0 (en) 1983-07-27
JPS6018765A (ja) 1985-01-30
NL8303571A (nl) 1985-01-16
FI833742A0 (fi) 1983-10-14
IT1194429B (it) 1988-09-22
FI833742L (fi) 1984-12-24
DK476083A (da) 1984-12-24

Similar Documents

Publication Publication Date Title
AU550510B2 (en) Marine seismic method and system
AU547546B2 (en) Occult blood detection
AU6919581A (en) Agglutination immunoassay
AU574670B2 (en) Seismic data transmission system
AU4493685A (en) Polyclonal antibodies, preparation and use
AU566054B2 (en) Immunoassay
AU554304B2 (en) Determination of carcinoembryonic antigen
AU548003B2 (en) Particle agglutination assay
AU6696781A (en) Detection of carcinoembryonic antigen
GB2136130B (en) Chemical assay systems and methods
GB8304538D0 (en) Antibodies and antigens
AU579324B2 (en) Reflective particle-containing analytical element
AU572117B2 (en) Unmasking delta antigens and determining antibodies therefor
AU3529889A (en) Specific cea-family antigens, antibodies specific and their methods of use
AU5444386A (en) Anti-nicotine and anti-cotinine antibodies (monoclonal and polyclonal)
GB8416902D0 (en) Antibody preparations
AU569816B2 (en) Monoclonal anti-alpha-amylase antibody
AU549683B2 (en) Automated reagent blotter
IL72269A0 (en) Specific binding assay methods and reagent systems
AU585833B2 (en) Estrogen-progesterone control reagents and methods for making same
AU8594382A (en) Immunoassay using biotin-avidin-enzyme complex
GB8506373D0 (en) Antigens antibodies
AU2017183A (en) Adenocarcinoma antigenic determinates and antibodies and reagent systems
AU559576B2 (en) Immunoassay
AU8196382A (en) Synthetic control and sera standard